IP Library › Granted Patent US 11,072,817
Granted Patent B2
US 11,072,817 · App. 15/683,066 · Granted Jul 27, 2021

Detection of DNA methylation

Inventors: Xiyu Jia (Newport Beach, CA); Onyinyechi Chimaokereke (Tustin, CA); Lam Nguyen (Fountain Valley, CA)
Assignee: ZYMO RESEARCH CORPORATION
C12Q1/6827
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,072,817
App. No.
15/683,066
Granted
Jul 27, 2021
Kind
B2
Abstract

In a first aspect, the invention concerns a method for detecting or quantifying DNA methylation at a locus. In one embodiment, a methylation-sensitive endonuclease is formulated together with a polymerase enzyme in an appropriate reaction mixture such that amplification of DNA occurs in a methylation specific manor. Quantitative DNA amplification at selected loci can be used to determine the level of methylation. Kits and reagents for performing such methods are also provided.

Claims (19)

1. A method for quantitating a proportion of methylation of a DNA sequence in a DNA sample comprising:

(i) contacting the DNA sample with a premixture comprising three methylation-sensitive endonucleases (MSEs), a thermal stable DNA polymerase, oligonucleotide primers for amplifying the DNA sequence, and a buffer formulated to facilitate activity of the MSEs and the DNA polymerase, thereby forming a reaction mixture, wherein the MSEs consist of AccII, Hpall, and HpyCH4IV;

(ii) incubating the reaction mixture under conditions permissive for cleaving the DNA sequence by the MSEs;

(iii) after step (ii), producing an amplified product by incubating the reaction mixture under conditions permissive for quantitative polymerase chain reaction (PCR); and

(iv) quantitating the proportion of methylation in the DNA sequence of the DNA sample by quantitating the amplified product,

wherein the volume of the reaction mixture is not adjusted during steps (ii)-(iii).

2. The method of claim 1 , wherein the MSEs are enzymes that do not cleave DNA at CpG methylated positions.

3. The method of claim 1 , wherein the DNA polymerase is a thermophilic polymerase.

4. The method of claim 1 , wherein the premixture further comprises a hot-start DNA polymerase.

5. The method of claim 1 , wherein said quantitating the proportion of methylation in the DNA sequence of the DNA sample comprises comparing the amount of the amplified product to an amplification standard, wherein the amplification standard is a DNA sample with a known proportion of methylation and a known amount.

6. The method of claim 1 , wherein the oligonucleotide primers comprise a label.

7. The method of claim 1 , wherein the premixture further comprises an oligonucleotide probe that hybridizes to the DNA sequence and comprises a label.

8. The method of claim 7 , wherein the label is a fluorescent label, a radioactive label, a sequence label, an enzymatic label or an affinity label.

9. The method of claim 1 , wherein the premixture comprises free nucleotides that comprise a label or a label that binds to a double-stranded DNA.

10. The method of claim 9 , wherein step (iv) further comprises detecting the label.

11. The method of claim 1 , wherein the DNA sample is a mammalian genomic DNA sample.

12. The method of claim 11 , wherein the mammalian genomic DNA sample is from a human subject, a cell line, or a tissue bank.

13. The method of claim 11 , wherein the mammalian genomic DNA sample is from a blood sample, a tissue biopsy sample, a urine sample, or a saliva sample.

14. The method of claim 1 , wherein the thermal stable DNA polymerase is a Taq polymerase.

Continuity (5)
Continuation 13581971
Provisional Application 61388766 · Oct 1, 2010
Provisional Application 61383408 · Sep 16, 2010
Provisional Application 61310201 · Mar 3, 2010
Related Publication 20180135113A1 · May 17, 2018